Cartilage Shaving (Chondroplasty) — Cost, Top Hospitals & Success Rates | MyMedicPlus

Cartilage shaving — clinically termed chondroplasty or arthroscopic debridement — is a minimally invasive surgical procedure performed via arthroscopy in which damaged, frayed, or fibrillated articular cartilage is smoothed and trimmed to a stable edge. The goal is to eliminate mechanical irritation caused by loose or irregularly surfaced cartilage within the joint, thereby reducing pain and improving function.

Articular cartilage — the smooth, glistening white tissue covering joint surfaces — is uniquely ill-equipped for self-repair due to its avascularity and low cell turnover. When cartilage becomes damaged through trauma, wear, or inflammatory arthritis, the resulting rough, unstable edges generate mechanical synovitis, pain, swelling, and accelerated joint degradation.

Chondroplasty can be performed using mechanical shaver blades, radiofrequency (RF) energy probes, or both. It is one of the most common additional procedures performed during diagnostic arthroscopy of the knee, and can also be applied to the shoulder, hip, and ankle. However, the procedure has significant limitations — it addresses the symptoms of cartilage damage without repairing or regenerating the underlying defect — and contemporary evidence has shifted emphasis toward biological cartilage repair techniques for younger patients with focal defects.

Understanding the appropriate indications and limitations of cartilage shaving is essential for patients and clinicians making informed treatment decisions.

Cartilage shaving is applied to a range of chondral and osteochondral pathologies, though its role varies considerably by diagnosis:

• Grade 1–3 Chondral Lesions (ICRS Classification): Focal or diffuse softening, fibrillation (fraying), or partial-thickness cartilage loss. Shaving stabilises the lesion edges and removes loose flaps that cause mechanical symptoms.
• Chondral Flaps: Partially detached cartilage fragments that fold and impinge in the joint, causing locking, catching, or sharp pain. Removal of the unstable flap provides rapid mechanical relief.
• Early Knee Osteoarthritis: In patients with mild to moderate OA (Kellgren-Lawrence grade 1–2) and mechanical symptoms, chondroplasty may provide short-term symptomatic relief when combined with treatment of concurrent pathology (meniscal tears, loose bodies).
• Patellar Chondromalacia: Softening and fibrillation of the patellar cartilage, often presenting as anterior knee pain worsened by stairs and prolonged sitting. Shaving of the patellar articular surface may supplement rehabilitation.
• Post-Traumatic Chondral Injury: Acute cartilage damage from sports injuries or falls. Debridement stabilises the lesion while biological repair options are assessed.
• Shoulder and Hip Cartilage Damage: Chondroplasty is also used arthroscopically in the glenohumeral joint (rotator cuff surgery context) and hip joint (FAI correction) to address co-existing articular cartilage damage.

Patient selection for cartilage shaving requires careful assessment of cartilage lesion characteristics, patient age, functional demand, and the overall joint environment:

• Mechanical symptoms: The primary indication is mechanical pain or locking from unstable cartilage flaps that correlate anatomically with the lesion on MRI or diagnostic arthroscopy.
• Lesion grade: Chondroplasty is most appropriate for Grade 1–3 lesions (ICRS). Full-thickness Grade 4 defects (bone exposed) require biological repair (microfracture, ACI, MACI, osteochondral grafting) rather than simple shaving.
• Patient age: Younger patients (<40) with isolated focal defects are better candidates for cartilage repair; chondroplasty alone in this group risks delaying definitive treatment. In older patients with diffuse OA, it may provide useful symptomatic palliation bridging to knee arthroplasty.
• Limb alignment: Significant varus (bowlegs) or valgus (knock-knees) malalignment concentrates stress on the affected compartment and reduces chondroplasty benefit. High tibial osteotomy should be considered to offload the damaged area.
• BMI: Obesity increases joint loading and reduces benefit duration; weight loss prior to surgery is strongly advised.
• Joint stability: Ligamentous instability (ACL deficiency) accelerates cartilage damage and should be addressed concurrently or before chondroplasty.

Preoperative MRI with cartilage-sensitive sequences (T2 mapping, dGEMRIC) characterises lesion depth, area, and associated subchondral bone change. Weight-bearing X-rays assess joint space narrowing and limb alignment.

Cartilage shaving is performed via arthroscopy using 2–3 small portal incisions. Technique depends on the instrument used and lesion characteristics:

Mechanical Shaving (Arthroscopic Debridement)

A motorised oscillating shaver with a protective window is introduced into the joint. The aggressive cutting side is directed at the damaged cartilage; suction removes debris. Different blade heads (full-radius, whisker, biter) allow targeted debridement of specific lesion types. The goal is to create a stable rim of healthy cartilage surrounding the defect, removing fibrillated or undermined edges.

Radiofrequency (RF) Chondroplasty

Monopolar or bipolar radiofrequency probes deliver thermal energy to cartilage edges, causing tissue contraction and protein cross-linking that stabilises the surface without mechanical cutting. RF chondroplasty may reduce debris generation and provide smoother final surface contours compared to mechanical shaving. Precautions are required to prevent thermal chondrocyte damage — pulse duration and energy settings must be carefully controlled.

Combined Debridement and Lavage

Arthroscopic joint lavage (irrigation with 5–10 litres of saline) removes inflammatory mediators, cartilage debris, and crystalline deposits (calcium pyrophosphate, basic calcium phosphate) from the joint space. Combined with debridement, lavage may provide additional short-term symptom relief, though controlled trials have not consistently demonstrated benefit of lavage alone.

As Adjunct to Biological Repair

Chondroplasty is routinely performed as preparation for subsequent biological repair. Debridement stabilises the lesion edges before microfracture, matrix-induced autologous chondrocyte implantation (MACI), or osteochondral autograft transfer (OATS/mosaicplasty) is performed.

In appropriately selected patients, cartilage shaving provides clinically meaningful advantages:

• Mechanical symptom relief: Removal of unstable cartilage flaps immediately eliminates impingement-type pain and catching within the joint.
• Minimally invasive: Performed through 2–3 keyhole incisions, with no open joint surgery, minimal blood loss, and same-day discharge.
• Rapid recovery: Patients typically return to daily activities within 1–2 weeks and to low-impact sport by 4–6 weeks.
• Diagnostic value: Arthroscopy provides definitive visual assessment of cartilage grade and associated pathology (menisci, ligaments, synovium) that guides subsequent management decisions.
• Bridge therapy: In patients not yet ready for major cartilage reconstruction or joint arthroplasty, chondroplasty can provide symptomatic palliation for 1–3 years.
• Low procedure risk: Complication rates are very low (infection <0.5%, DVT <1%) for brief arthroscopic procedures.

Patients must be aware of both procedural complications and fundamental limitations of cartilage shaving:

• No cartilage regeneration: The most important limitation. Chondroplasty smoothes existing damaged cartilage but does not regenerate it. The underlying defect remains and will continue to progress. Over time, most patients experience recurrence of symptoms as disease advances.
• Thermal chondrocyte damage (RF): Excessive radiofrequency energy application can damage or kill viable chondrocytes in surrounding cartilage, potentially accelerating cartilage loss. Requires strict technique adherence.
• Chondrocyte release and debris: Mechanical shaving releases cartilage fragments and cells into the joint fluid. While most are cleared by synovial macrophages, excessive debris can cause reactive synovitis and accelerate OA progression.
• Infection: Septic arthritis occurs in <0.1–0.5% of arthroscopic procedures. Requires immediate joint washout and antibiotics.
• DVT / PE: Low but present risk; higher in obese, immobile, or high-risk patients.
• Persistent pain: 20–30% of patients (particularly those with advanced OA or full-thickness lesions) do not achieve satisfactory relief from chondroplasty alone.
• Delayed definitive treatment: In young patients, chondroplasty without addressing the underlying defect may delay cartilage repair procedures and allow lesion progression.
• Evidence controversy: The landmark Moseley et al. NEJM 2002 sham-controlled trial showed arthroscopic debridement and lavage provided no benefit over placebo in knee OA. This has significantly narrowed the indications for standalone chondroplasty in OA.

Post-chondroplasty recovery is structured around physiotherapy and monitoring of symptoms:

Day of Surgery

The procedure takes 20–60 minutes under general, spinal, or regional block anaesthesia. Patients are discharged home within 2–4 hours. A compression bandage reduces swelling. Weight bearing is typically permitted immediately as tolerated, with crutches offered if needed.

Days 1–10

Ice packs (20 minutes, 3–4 times daily) and limb elevation reduce post-operative swelling and pain. Portal wounds are kept dry for 5–7 days. Gentle range-of-motion exercises begin on day 1. Analgesics (paracetamol, NSAIDs) are prescribed for 5–7 days. Physiotherapy assessment is recommended within the first week.

Weeks 2–6

Physiotherapy focuses on quadriceps strengthening, proprioception, and low-impact cardiovascular exercise (cycling, swimming). Walking normalises by 2 weeks. Patients with desk-based work return by week 1–2; manual labour jobs at 4–6 weeks. Swelling may persist for 4–6 weeks, especially with concurrent meniscal or synovial procedures.

Weeks 6–12 and Beyond

Low-impact sport (cycling, swimming, golf) resumes at 4–6 weeks. Running and higher-impact activities begin at 6–12 weeks, contingent on symptom resolution and strength recovery. Ongoing physiotherapy (strengthening, neuromuscular control) is important to reduce joint loading and slow OA progression. Annual reassessment is recommended to monitor cartilage status and guide future management.

Cartilage shaving as a standalone arthroscopic procedure is generally less expensive than meniscal surgery or cartilage repair, though costs vary significantly by setting:

• United States: $3,000–$10,000 (outpatient surgical centre, standalone chondroplasty); higher if combined with meniscectomy or RF devices
• United Kingdom: £2,500–£7,000 (private); NHS availability depends on regional policy and clinical criteria
• India: $800–$2,500 — World-class arthroscopic programs in NABH/JCI-accredited centres
• Thailand: $1,500–$4,000 — Comprehensive joint care in Bangkok's international hospitals
• Turkey: $1,000–$3,500 — Modern arthroscopy units with experienced orthopedic teams
• Germany: $4,000–$9,000 — Advanced cartilage centres with access to biological repair alongside chondroplasty

Cost drivers: concurrent procedures (meniscectomy, loose body removal, synovectomy), instrumentation type (RF vs. mechanical), anaesthesia, implant materials for biological repair if added, and physiotherapy program duration. Patients travelling internationally for chondroplasty should pre-arrange physiotherapy at home to ensure a structured rehabilitation course begins promptly upon return.

Given the limited evidence for standalone chondroplasty, particularly in OA patients, clinicians increasingly favour the following alternatives depending on patient age, lesion grade, and functional demand:

Conservative Management (First Line)

• Physiotherapy: Quadriceps and hip abductor strengthening, aerobic exercise, and neuromuscular training demonstrably reduce knee pain and improve function in OA and chondral pathology.
• NSAIDs and analgesics: Oral or topical NSAIDs provide meaningful pain control for articular cartilage inflammation.
• Intra-articular injections: Corticosteroids (fast-onset, 4–12 week effect) or hyaluronic acid (slower-onset, potentially 6 month effect) reduce pain and synovitis without surgery.
• Platelet-Rich Plasma (PRP): Emerging biological therapy; particularly promising in early OA and chondral lesions, with growing evidence for sustained benefit.

Biological Cartilage Repair (Preferred in Young Patients)

• Microfracture: Awl-penetration of the subchondral bone to release bone marrow cells that form fibrocartilage repair tissue. Effective for small defects (<2 cm²) in young patients. Simple, low-cost, but produces fibrocartilage rather than hyaline cartilage.
• MACI / ACI (Autologous Chondrocyte Implantation): Chondrocytes are harvested, expanded ex vivo, and implanted into the defect on a collagen membrane. Produces near-hyaline quality repair tissue. Best evidence for medium to large defects in patients under 50.
• OATS / Mosaicplasty (Osteochondral Autograft Transfer): Cylindrical osteochondral plugs are harvested from non-load-bearing areas and transplanted into the defect. Provides immediate structural fill with genuine hyaline cartilage.
• Osteochondral Allograft Transplantation: Cadaveric osteochondral tissue fills large defects unsuitable for autograft or ACI.

Joint Offloading and Replacement

• Unloader bracing / custom orthoses: Shift load away from the damaged compartment.
• High Tibial Osteotomy (HTO): Realigns the limb to unload the damaged compartment; can extend joint life by 10–15 years in varus OA patients.
• Unicompartmental or Total Knee Arthroplasty: Definitive treatment for advanced OA when conservative and joint-preserving options are exhausted.